RosentradeAktien. Watchlist. Boersenspiel.
$ €
Deutsch English
    $ €
    Deutsch English

    Celyad Oncology SA

    CYAD.BR

    0.26 EUR

    1 Tag: -3.69% (-0.01 EUR)

    Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.

    Kursalarme fuer CYAD.BR

    Bitte anmelden, um Kursalarme zu sehen und zu speichern.

    Finanzen

    Umsatz21.00 Tsd. EUR
    EBITDA-1.52 Mio. EUR
    Nettogewinn830.00 Tsd. EUR
    Market Cap12.34 Mio. EUR
    KGV13.05
    Div. RenditeN/A
    52W Hoch0.65 EUR
    52W Tief0.16 EUR

    Kurschart

    Chart wird geladen...
    Unternehmensinfo

    Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

    Aktuelle News